Detalhe da pesquisa
1.
Repurposing FIASMAs against Acid Sphingomyelinase for COVID-19: A Computational Molecular Docking and Dynamic Simulation Approach.
Molecules
; 28(7)2023 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37049752
2.
The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir disoproxil fumarate/emtricitabine/efavirenz.
AIDS
; 35(Suppl 2): S117-S125, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261099